These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3720370)

  • 1. Short-course chemotherapy for pleural tuberculosis. Nine years' experience in routine treatment service.
    Dutt AK; Moers D; Stead WW
    Chest; 1986 Jul; 90(1):112-6. PubMed ID: 3720370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
    Long MW; Snider DE; Farer LS
    Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course chemotherapy of tuberculosis with largely twice-weekly isoniazid-rifampin.
    Dutt AK; Jones L; Stead WW
    Chest; 1979 Apr; 75(4):441-7. PubMed ID: 446131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculous pleural effusion: 6-month therapy with isoniazid and rifampin.
    Dutt AK; Moers D; Stead WW
    Am Rev Respir Dis; 1992 Jun; 145(6):1429-32. PubMed ID: 1596014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculous pleural effusion and lymphadenitis treated with rifampin-containing regimen.
    Malik SK; Behera D; Gilhotra R
    Chest; 1987 Nov; 92(5):904-5. PubMed ID: 3665607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undesirable side effects of isoniazid and rifampin in largely twice-weekly short-course chemotherapy for tuberculosis.
    Dutt AK; Moers D; Stead WW
    Am Rev Respir Dis; 1983 Sep; 128(3):419-24. PubMed ID: 6614636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short course chemotherapy for tuberculosis in children.
    Padmini R; Srinivasan S; Nalini P; Mahadevan S
    J Trop Pediatr; 1993 Dec; 39(6):361-4. PubMed ID: 8133559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
    Zierski M
    Scand J Respir Dis Suppl; 1978; 102():48-52. PubMed ID: 278215
    [No Abstract]   [Full Text] [Related]  

  • 11. Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial.
    Snider DE; Long MW; Cross FS; Farer LS
    Am Rev Respir Dis; 1984 Apr; 129(4):573-9. PubMed ID: 6370060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculous pleural effusion: experience with six months of treatment with isoniazid and rifampicin.
    Cañete C; Galarza I; Granados A; Farrero E; Estopà R; Manresa F
    Thorax; 1994 Nov; 49(11):1160-1. PubMed ID: 7831634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
    Dutt AK; Moers D; Stead WW
    Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1232-5. PubMed ID: 2111106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smear- and culture-negative pulmonary tuberculosis: four-month short-course chemotherapy.
    Dutt AK; Moers D; Stead WW
    Am Rev Respir Dis; 1989 Apr; 139(4):867-70. PubMed ID: 2930066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course chemotherapy for tuberculosis in children.
    Abernathy RS; Dutt AK; Stead WW; Moers DJ
    Pediatrics; 1983 Dec; 72(6):801-6. PubMed ID: 6606156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of extrapulmonary tuberculosis.
    Dutt AK; Stead WW
    Semin Respir Infect; 1989 Sep; 4(3):225-31. PubMed ID: 2688005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of short-term chemotherapy of tuberculosis. III. Early and late results of 6 months' treatment of tuberculosis. Analysis of failures and recurrences during 1-5 years' observation].
    Nikodemowicz E; Kamińska M; Kopeć H; Maternowska W; Prus F; Sembratowicz L
    Pneumonol Pol; 1986 Jan; 54(1):9-15. PubMed ID: 3714521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.